Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
- April -
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
- 2022 -
2023
-
2024
-
2025
April 2022 - 77 products
IP
Sitagliptin-Metformin-
Mepha 50/850 mg
196
PR
PR
k.A.
Coated tablets: 2 Active Agents
Mepha Pharma AG
B
FB
G
IP
Sitagliptin-Metformin-
Mepha 50/1000 mg
196
PR
PR
k.A.
Coated tablets: 2 Active Agents
Mepha Pharma AG
B
FB
G
IP
Tenkasi 1200 mg
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Oritavancinum 1200 mg
A. Menarini GmbH
A
FB
G
L
IP
CI
Rivaroxaban-Mepha
vascular 2.5 mg
Filmtabletten
56
26.83
45.60
10 %
Rivaroxabanum 2.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban-Mepha
vascular 2.5 mg
Filmtabletten
100
47.91
68.50
10 %
Rivaroxabanum 2.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban-Mepha
vascular 2.5 mg
Filmtabletten
196
93.92
118.55
10 %
Rivaroxabanum 2.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Treprostinil Ideogen 1
mg/mL
20 ml
2176.71
2383.70
10 %
Infusion solution: Treprostinilum 1 mg/ml
Ideogen AG
B / SL / SG
FB
G
L
IP
Treprostinil Ideogen 2.5
mg/mL
20 ml
4451.12
4857.30
10 %
Infusion solution: Treprostinilum 2.5 mg/ml
Ideogen AG
B / SL / SG
FB
G
L
IP
Treprostinil Ideogen 5
mg/mL
20 ml
8902.24
9441.50
10 %
Infusion solution: Treprostinilum 5 mg/ml
Ideogen AG
B / SL / SG
FB
G
L
IP
Treprostinil Ideogen 10
mg/mL
20 ml
17804.48
18575.20
10 %
Infusion solution: Treprostinilum 10 mg/ml
Ideogen AG
B / SL / SG
FB
G
IP
CI
Olmesartan-HCT-Mepha Teva
20/12.5 mg
28
13.46
31.05
10 %
Coated tablets: Hydrochlorothiazidum 12.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Olmesartan-HCT-Mepha Teva
40/12.5 mg
28
15.42
33.25
10 %
Coated tablets: Hydrochlorothiazidum 12.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Olmesartan-HCT-Mepha Teva
20/12.5 mg
98
40.04
59.95
10 %
Coated tablets: Hydrochlorothiazidum 12.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Olmesartan-HCT-Mepha Teva
40/12.5 mg
98
51.08
72.00
10 %
Coated tablets: Hydrochlorothiazidum 12.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Olmesartan-HCT-Mepha Teva
20/25 mg
28
13.46
31.05
10 %
Coated tablets: Hydrochlorothiazidum 25 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Olmesartan-HCT-Mepha Teva
40/25 mg
28
17.18
35.10
10 %
Coated tablets: Hydrochlorothiazidum 25 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Olmesartan-HCT-Mepha Teva
20/25 mg
98
40.04
59.95
10 %
Coated tablets: Hydrochlorothiazidum 25 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Olmesartan-HCT-Mepha Teva
40/25 mg
98
51.08
72.00
10 %
Coated tablets: Hydrochlorothiazidum 25 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Sitagliptin-Metformin-
Mepha 50/500 mg
56
9.50
26.75
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
● 
B / SL / SG
FB
G
L
IP
CI
Sitagliptin-Metformin-
Mepha 50/500 mg
196
33.27
52.60
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Sitagliptin-Metformin-
Mepha 50/850 mg
56
9.50
26.75
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Sitagliptin-Metformin-
Mepha 50/850 mg
100
16.97
34.85
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Sitagliptin-Metformin-
Mepha 50/850 mg
196
33.27
52.60
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Sitagliptin-Metformin-
Mepha 50/1000 mg
56
9.50
26.75
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Sitagliptin-Metformin-
Mepha 50/1000 mg
100
16.97
34.85
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Sitagliptin-Metformin-
Mepha 50/1000 mg
196
33.27
52.60
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
● 
B / SL / SG
FB
G
L
IP
CI
Lenalidomid Viatris 2.5 mg
21
689.23
766.00
10 %
Capsules: Lenalidomidum 2.5 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
L
IP
Lenalidomid Viatris 5 mg
21
707.76
786.15
10 %
Capsules: Lenalidomidum 5 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
L
IP
Lenalidomid Viatris 7.5 mg
21
726.28
806.30
10 %
Capsules: Lenalidomidum 7.5 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
L
IP
Lenalidomid Viatris 10 mg
21
744.81
826.45
10 %
Capsules: Lenalidomidum 10 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
L
IP
Lenalidomid Viatris 15 mg
21
782.79
867.75
10 %
Capsules: Lenalidomidum 15 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
L
IP
Lenalidomid Viatris 20 mg
21
821.96
910.35
10 %
Capsules: Lenalidomidum 20 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
L
IP
Lenalidomid Viatris 25 mg
21
861.14
952.95
10 %
Capsules: Lenalidomidum 25 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
IP
CI
Clobetasol Leman 0.5mg/g
125 ml
12.50
30.00
10 %
shampoing: Clobetasoli Propionas
Leman SKL SA
B / SL / SG
FB
G
L
IP
CI
Vitamin D3 Streuli 20`000
I.E. Weichkapseln
4
4.22
13.80
10 %
Cholecalciferolum 20000 UI
Streuli Pharma AG
B / SL
FB
G
L
IP
CI
Vitamin D3 Streuli 20`000
I.E. Weichkapseln
12
12.66
30.20
10 %
Cholecalciferolum 20000 UI
Streuli Pharma AG
B / SL
FB
G
L
IP
CI
Hukyndra 40mg/0.4ml
367.04
415.80
10 %
Injection solution in prefilled syringe: Adalimumabum 40mg / 0.4ml
Spirig HealthCare AG
B / SL
FB
G
L
IP
CI
Hukyndra 80mg/0.8ml
710.68
787.15
10 %
Injection solution in prefilled syringe: Adalimumabum 80mg / 0.8ml
Spirig HealthCare AG
B / SL
FB
G
L
IP
CI
Hukyndra 40mg/0.4ml
2
734.08
815.20
10 %
Injection solution in prefilled syringe: Adalimumabum 40mg / 0.4ml
Spirig HealthCare AG
B / SL
FB
G
L
IP
CI
Hukyndra 40mg/0.4ml
6
2202.24
2405.40
10 %
Injection solution in prefilled syringe: Adalimumabum 40mg / 0.4ml
Spirig HealthCare AG
B / SL
FB
G
L
IP
CI
Cibinqo 50 mg
28
937.81
1036.35
10 %
Coated tablets: Abrocitinibum 50 mg
Pfizer AG
B / SL
FB
G
L
IP
Cibinqo 100 mg
28
937.81
1036.35
10 %
Coated tablets: Abrocitinibum 100 mg
Pfizer AG
B / SL
FB
G
L
IP
CI
Ezetimib-Rosuvastatin-
Mepha 10 mg / 5 mg
30
21.27
39.55
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL
FB
G
L
IP
CI
Ezetimib-Rosuvastatin-
Mepha 10 mg / 5 mg
90
63.81
85.80
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL
FB
G
L
IP
Ezetimib-Rosuvastatin-
Mepha 10 mg / 10 mg
30
25.05
43.65
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL
FB
G
L
IP
Ezetimib-Rosuvastatin-
Mepha 10 mg / 10 mg
90
75.15
98.15
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL
FB
G
L
IP
Ezetimib-Rosuvastatin-
Mepha 10 mg / 20 mg
30
28.83
47.75
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL
FB
G
L
IP
Ezetimib-Rosuvastatin-
Mepha 10 mg / 20 mg
90
86.50
110.50
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL
FB
G
L
IP
CI
Vitarubin Oral
30
9.69
17.90
10 %
Coated tablets: Cyanocobalaminum 1 mg
Streuli Pharma AG
D / SL
FB
G
L
IP
CI
Vitarubin Oral
100
20.07
37.05
10 %
Coated tablets: Cyanocobalaminum 1 mg
Streuli Pharma AG
D / SL
FB
G
L
IP
CI
Hukyndra 40mg/0.4ml
367.04
415.80
10 %
Injektionslösung im Fertigpen: Adalimumabum 40mg / 0.4ml
Spirig HealthCare AG
B / SL
FB
G
L
IP
CI
Hukyndra 40mg/0.4ml
2
734.08
815.20
10 %
Injektionslösung im Fertigpen: Adalimumabum 40mg / 0.4ml
Spirig HealthCare AG
B / SL
FB
G
L
IP
CI
Hukyndra 40mg/0.4ml
6
2202.24
2405.40
10 %
Injektionslösung im Fertigpen: Adalimumabum 40mg / 0.4ml
Spirig HealthCare AG
B / SL
FB
G
L
IP
Tenkasi 400 mg
3
2063.40
2260.50
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Oritavancinum 400 mg
A. Menarini GmbH
A / SL
FB
G
IP
CI
NexoBrid
1 +
PR
PR
k.A.
Triskel INTEGRATED
SERVICES SA
A
FB
G
IP
CM
Zeller Wechseljahre
30
PR
PR
k.A.
Max Zeller Söhne AG
D
FB
G
IP
CM
Zeller Wechseljahre forte
30
PR
PR
k.A.
Max Zeller Söhne AG
D
FB
G
IP
CM
Zeller Wechseljahre
90
PR
PR
k.A.
Max Zeller Söhne AG
D
FB
G
IP
CM
Zeller Wechseljahre forte
90
PR
PR
k.A.
Max Zeller Söhne AG
D
FB
G
CI
CM
GEM Bronchialpastillen neo
40
PR
PR
k.A.
Pastilles: 6 Active Agents
Tentan AG
E
FB
G
IP
CI
Cibinqo 50 mg
14
PR
PR
k.A.
Coated tablets: Abrocitinibum 50 mg
Pfizer AG
B
FB
G
IP
CI
Cibinqo 50 mg
91
PR
PR
k.A.
Coated tablets: Abrocitinibum 50 mg
Pfizer AG
B
FB
G
IP
Cibinqo 100 mg
14
PR
PR
k.A.
Coated tablets: Abrocitinibum 100 mg
Pfizer AG
B
FB
G
IP
Cibinqo 100 mg
91
PR
PR
k.A.
Coated tablets: Abrocitinibum 100 mg
Pfizer AG
B
FB
G
Ibu-Lysin Fairmed 200 mg
20
PR
PR
k.A.
Coated tablets: Ibuprofenum 200 mg
Strides Pharma
International AG
D
FB
G
Ibu-Lysin Fairmed 400 mg
10
PR
PR
k.A.
Coated tablets: Ibuprofenum 400 mg
Strides Pharma
International AG
D
FB
G
Rivaroxaban NOBEL 10 mg
10
PR
PR
k.A.
Coated tablets: Rivaroxabanum 10 mg
NOBEL Pharma Schweiz AG
B
FB
G
Rivaroxaban NOBEL 10 mg
30
PR
PR
k.A.
Coated tablets: Rivaroxabanum 10 mg
NOBEL Pharma Schweiz AG
B
FB
G
Rivaroxaban NOBEL 10 mg
100
PR
PR
k.A.
Coated tablets: Rivaroxabanum 10 mg
NOBEL Pharma Schweiz AG
B
FB
G
Rivaroxaban NOBEL 15 mg
15
PR
PR
k.A.
Coated tablets: Rivaroxabanum 15 mg
NOBEL Pharma Schweiz AG
B
FB
G
Rivaroxaban NOBEL 15 mg
28
PR
PR
k.A.
Coated tablets: Rivaroxabanum 15 mg
NOBEL Pharma Schweiz AG
B
FB
G
Rivaroxaban NOBEL 15 mg
98
PR
PR
k.A.
Coated tablets: Rivaroxabanum 15 mg
NOBEL Pharma Schweiz AG
B
FB
G
Rivaroxaban NOBEL 20 mg
14
PR
PR
k.A.
Coated tablets: Rivaroxabanum 20 mg
NOBEL Pharma Schweiz AG
B
FB
G
Rivaroxaban NOBEL 20 mg
28
PR
PR
k.A.
Coated tablets: Rivaroxabanum 20 mg
NOBEL Pharma Schweiz AG
B
FB
G
Rivaroxaban NOBEL 20 mg
98
PR
PR
k.A.
Coated tablets: Rivaroxabanum 20 mg
NOBEL Pharma Schweiz AG
B
FB
G
CI
Colibiogen oral
100 ml
PR
PR
k.A.
Solution (oral): Escherichiae coli Lysatum (Stamm Laves) 760-870 mg/ml
Laves-Arzneimittel
Gesellschaft mit
beschränkter Haftung,
Ronnenberg,
Zweigniederlassung
Schötz
D
FB
G
IP
CI
Bimatoprost Labatec 0.3
mg/ml
3 ml
PR
PR
k.A.
collyre en solution: Bimatoprostum
Labatec Pharma SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home